JerryBagelMDMS

Dermatology • East Windsor, NJ

Director:Psoriasis Treatment Center of Central New Jersey

Join to view full profile

Dr. Bagel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bagel's full profile

Already have an account?

Office
59 One Mile Rd
Ste G
East Windsor, NJ 08520
Phone+1 609-443-4500

Fax+1 609-443-4808
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Dermatology, 1982 - 1985
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1981 - 1982
Icahn School of Medicine at Mount SinaiClass of 1981
Rutgers UniversityM.S., Biochemistry, 1977
Boston UniversityB.A., Biology, Cum Laude, 1975

Certifications & Licensure

NJ State Medical License 1984 - 2025
FL State Medical License 1982 - 1987
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

NPF Physician-Clinician of the Year Award National Psoriasis Foundation, 2016
AAD Presidential Citation For Excellence In Psoriasis Research American Academy of Dermatology, 2016
MCMS Award For Research And Patient Outreach Mercer County Medical Society, 2016
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
Inside Jersey: Top Cosmetic Doctors Castle Connolly, 2011
NJ.com Top Doctors Castle Connolly, 2009
Inside Jersey: Top Doctor 2009-2011
Patients' Choice Award 2008
Volunteer of the Year National Psoriasis Foundation, 2007
President's Council Leader National Psoriasis Foundation, 2006
Doctor of the Year New Jersey Life, 2005
New Jersey Life: Top Doctors Castle Connolly, 2005
New York Metro Area: Top Doctor 2004-2008, 2012-2013
New Jersey Monthly: Top Doctors Castle Connolly, 2001, 2003
Golden Triangle Award 2002
Doctor of the Year New Jersey Magazine, 2001, 2003
Robert Wood Johnson Distinguished Volunteer Faculty Award 1997
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Start of enrollment: 2007 Jun 01
Completed
Not Applicable
NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study Start of enrollment: 2007 Apr 01
Completed
Not Applicable
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
Completed
Phase 3
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life Start of enrollment: 2013 Jul 01
Completed
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy Start of enrollment: 2007 Mar 01
Completed
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
Enstilar in Combination With Biologic Agents Start of enrollment: 2017 May 01
Completed
Phase 4
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients Start of enrollment: 2017 Nov 07
Recruiting
Not Applicable
Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis Start of enrollment: 2018 Jul 23
Completed
Phase 4
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
Completed
Phase 2
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis Start of enrollment: 2019 Jan 16
Recruiting
Phase 4
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Terminated
Phase 2
An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers Start of enrollment: 2019 Jul 31
Completed
Duobrii in Combination With Biologics Start of enrollment: 2019 Oct 14
Recruiting
Phase 4
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. Start of enrollment: 2020 Apr 06
Recruiting
Phase 4
Taltz in Combination With Enstilar for Psoriasis Start of enrollment: 2020 Apr 28
Recruiting
Phase 4
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry.
Sima, A., Janak, J., Patel, M., Photowala, H., Garg, V., Strober, B., Duffin, K., Lebwohl, M., Bagel, J.> ;The Journal of Dermatological Treatment. 2024 Dec 1
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled...
Kurt Gebauer, Lynda Spelman, Tushar Nishandar, Michael Crane, Mudgal Kothekar, Siu-Long Yao, Paul S Yamauchi, Jerry Bagel, Iris Kopeloff, Howard L Sofen> ;Journal of the American Academy of Dermatology. 2024 Mar 28
1 citations
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-lab...
Linda F Stein Gold, Jerry Bagel, Stephen K Tyring, H Chih-Ho Hong, Lev Pavlovsky, Ronald Vender, Andreas Pinter, Adam Reich, Leonidas Drogaris, Tianshuang Wu, Manish P...> ;The British Journal of Dermatology. 2023 Oct 25
4 citations
Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial.
Jerry Bagel, Linda Stein Gold, James Del Rosso, Sandy Johnson, Paul Yamauchi, Philip M Brown, Neal Bhatia, Angela Yen Moore, Anna M Tallman> ;Journal of the American Academy of Dermatology. 2023 Nov 1
2 citations
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary.
Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B Gordon, Peter Foley, Phoebe Rich, Carle Paul, Jerry Bagel, Elizabeth Colston, John Throup, Sudeep Ku...> ;Immunotherapy. 2023 Aug 1
2 citations
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study.
Andrew Blauvelt, David M Pariser, Stephen Tyring, Jerry Bagel, Andrew F Alexis, Jennifer Soung, April W Armstrong, Elisa Muscianisi, Farid Kianifard, Jennifer Steadman...> ;Journal of Dermatological Science. 2023 Jan 1
Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort.
Katrina Abuabara, Lawrence F Eichenfield, Robert Bissonnette, Jonathan I Silverberg, Jerry Bagel, Emma Guttman-Yassky, Diamant Thaci, Eric L Simpson, John E Harris, Ja...> ;Journal of the American Academy of Dermatology. 2023 Aug 1
Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry.
Chen Yu, Gang Wang, Russel T Burge, Erjia Ye, Guanshen Dou, Jinnan Li, Ryan W Harrison, Robert R McLean, Samantha J Kerti, Jerry Bagel> ;Dermatology and Therapy. 2023 Jan 1
29 citations
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
Mark G Lebwohl, Leon H Kircik, Angela Y Moore, Linda Stein Gold, Zoe D Draelos, Melinda J Gooderham, Kim A Papp, Jerry Bagel, Neal Bhatia, James Q Del Rosso, Laura K F...> ;JAMA. 2022 Sep 20
65 citations
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3...
Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B Gordon, Peter Foley, Phoebe Rich, Carle Paul, Jerry Bagel, Elizabeth Colston, John Throup, Sudeep Ku...> ;Journal of the American Academy of Dermatology. 2023 Jan 1
18 citations
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a rand...
Matthias Augustin, Kristian Reich, Paul Yamauchi, Andreas Pinter, Jerry Bagel, Swapnil Dahale, Ruquan You, Gerard Bruin, Jimena Djimopoulos, Bertrand Paguet, Pascal Ch...> ;The British Journal of Dermatology. 2022 Jun 1
4 citations
Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE).
Jerry Bagel, Tien Q Nguyen, Hermenio Lima, Neal Jain, David M Pariser, Sylvia Hsu, Gil Yosipovitch, Haixin Zhang, Jingdong Chao, Shikha Bansal, Zhen Chen, Daniel Richm...> ;Dermatology and Therapy. 2022 Jun 1
Adjunctive Use of Halobetasol Propionate-Tazarotene in Biologic-Experienced Patients With Psoriasis.
Jerry Bagel, Kristin Novak, Elise Nelson> ;Cutis. 2022 Feb 1
51 citations
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
Mark G Lebwohl, Linda Stein Gold, Bruce Strober, Kim A Papp, April W Armstrong, Jerry Bagel, Leon Kircik, Benjamin Ehst, H Chih-Ho Hong, Jennifer Soung, Jeff Fromowitz...> ;The New England Journal of Medicine. 2021 Dec 9
4 citations
IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.
Amy S. Paller, J K L Tan, Jerry Bagel, Ana B. Rossi, Brad Shumel, Haixin Zhang, A Abramova> ;The British Journal of Dermatology. 2021 Nov 2
13 citations
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.
Andrew Blauvelt, April W. Armstrong, Richard G. Langley, Kurt Gebauer, Diamant Thaçi, Jerry Bagel, Lyn Guenther, Carle Paul, Bruce Randazzo, Susan Flavin, Ming-Chun Hs...> ;The Journal of Dermatological Treatment. 2021 Aug 4
2 citations
Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2.
Peter Foley, Kristian Reich, Andrew Blauvelt, Jerry Bagel, Richard G. Langley, Megan Miller, Paraneedharan Ramachandran, Ya-Wen Yang, Yaung-Kaung Shen, Yin You, Mark L...> ;Journal of Drugs in Dermatology. 2021 Aug 1
4 citations
Effect of Baseline Disease Severity on Achievement of Treatment Target With Apremilast: Results From a Pooled Analysis
Kristian Reich, Ulrich Mrowietz, Alan Menter, Cem Griffiths, Jerry Bagel, Bruce Strober, N Nunez Gomez, Rebecca Shi, B Guerette, Mark Lebwohl> ;Journal of the European Academy of Dermatology and Venereology. 2021 Jul 13
1 citations
Treatment strategies, management of comorbidities, and the role of IL-23 inhibitors in moderate to severe psoriasis.
Jerry Bagel> ;The American Journal of Managed Care. 2021 Jun 1
6 citations
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque...
Andrew Blauvelt, Kenneth B. Gordon, Patricia C. Lee, Jerry Bagel, Howard Sofen, Benjamin Lockshin, Ahmed M. Soliman, Ziqian Geng, Tianyu Zhan, Gabriela Alperovich, Lin...> ;The Journal of Dermatological Treatment. 2021 May 5
76 citations
Bimekizumab versus Adalimumab in Plaque Psoriasis.
Richard B. Warren, Andrew Blauvelt, Jerry Bagel, Kim A. Papp, Paul S. Yamauchi, April W. Armstrong, Richard G. Langley, Veerle Vanvoorden, Dirk De Cuyper, Christopher ...> ;The New England Journal of Medicine. 2021 Apr 23
1 citations
A Retrospective Review of Patients' Response to Biologic Therapy for Psoriasis.
Jerry Bagel, Brianna Butler, Elise Nelson, Alexa Hetzel> ;Journal of Drugs in Dermatology. 2021 Apr 1
3 citations
Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study.
A.S. Van Voorhees, L. Stein Gold, Mark Lebwohl, Bruce Strober, Howard Sofen, Kim Papp, Jerry Bagel, Z. Zhang, Maria Paris, Y. Wang> ;The British Journal of Dermatology. 2021 Mar 24
21 citations
Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic de...
Joseph F. Merola, Jerry Bagel, Peter Almgren, Mads A. Røpke, Katja W. Lophaven, Natacha Strange Vest, Parbeer Grewal> ;Journal of the American Academy of Dermatology. 2021 Jul 1
28 citations
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results...
Jerry Bagel, Andrew Blauvelt, John K Nia, Peter W Hashim, Manmath Patekar, A. de Vera, K Ahmad, Bertrand Paguet, Summer Xia, Elisa Muscianisi, Mark Lebwohl> ;Journal of the European Academy of Dermatology and Venereology. 2021 Jan 1
Join now to see all

Journal Articles

Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis Foundation
Ronald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA
M2688 The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethosone Dipropionate Improves the Helath-Related Quality of Life in Patients with ...
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology (JDD), 7/2016
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethosone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoria...
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology (JDD), 1/1/2016
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Jerry Bagel, M.D., et al, The New England Journal of Medicine, 10/2015
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris-A randomized phase II study
Jerry Bagel, M.D., et al, Journal of Dermatological Treatment, 1/1/2015
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current thera...
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2014
Clinical Study Results of Desoximetasone Spray, 025% In Moderate to Severe Plaque Psoriasis
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2013
Consensus Guidelines for the Management of Plaque Psoriasis
Jerry Bagel, M.D., et al, Archives of Dermatology, 1/1/2012
Moderate to Severe Plaque Psoriasis with Scalp Involvement: A Randomized, Double-Blind, Placebo-Controlled Study of Etanercept
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2012
Adalimumab plus Narrowband Ultraviolet B Light Phototherapy for the Treatment of Moderate to Severe Psoriasis
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2011
A Review of Phototherapy Protocols for Psoriasis Treatment
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2011
Adalimumab Plus Narrowband Ultraviolet B Light Phototherapy for the Treatment of Moderate to Severe Psoriasis
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology, 1/1/2011
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet: Efficacy and Safety Results from REACH, a Randomized, Placebo-Controlled...
Jerry Bagel, M.D., et al, Archives of Dermatology, 1/1/2011
Optomizing Topical Therapies for Treating Psoriasis: A Consensus Conference
Jerry Bagel, M.D., et al, Cutis, 1/1/2010
Topical Therapies for the Treatment of Plaque Psoriasis
Jerry Bagel, M.D., Cutaneous Medicine for the Practitioner, 1/1/2009
Treatment of intertriginous psoriasis: From the Medical Board of National Psoriasis Foundation
Jerry Bagel, M.D, Kalb, Korman et al, J Am Acad Dermatology, 1/1/2009
Understanding PML and Risks Associated with Biologic Therapies
Jerry Bagel, M.D., et al, Practical Dermatology, 1/1/2009
Treatment of Effective Therapy: Lead Psoriasis Patients along the Path to Clearance
Jerry Bagel, M.D., et al, Practical Dermatology, 1/1/2009
LCD plus NB-UVB reduces Time to Improvement of Psoriasis vs NB-UVB Alone
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology, 1/1/2009
Treatment of intertiginous psoriasis: From the Medical Board of the National Psoriasis Foundation
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2009
Topical Psoriasis Therapy: Patients' Experiences, Physicians' Perceptions Don't Always Match
Jerry Bagel, M.D., et al, Practical Dermatology, 1/1/2008
Utilization of Narrow-Band Ultraviolet Light B Therapy and Etanercept for the Treatment of Psoriasis (UNITE): Efficacy, Safety, and Patient-Reported Outcomes
Jerry Bagel, M.D., et al, Journal of Drugs in Dermatology, 1/1/2008
From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2008
Assessment and tracking of long-term alefacept safety
Jerry Bagel, M.D., et al, Journal of the American Academy of Dermatology, 1/1/2007
National Psoriasis Foundation Clinical Consensus on Disease Severity
Jerry Bagel, M.D., et al, Archives of Dermatology, 1/1/2007
Join now to see all

Other

Treatment of Pediatric Psoriasis
Jerry Bagel, M.D., Practical Dermatology
1/1/2010
Clearing Psoriasis: The Role of a Novel 2-Compoound Ointment as First-Line Therapy.
Jerry Bagel, M.D., et al, Skin & Allergy News
1/1/2007
Be Prepared to Treat Pustular Psoriasis-An Uncommon Variant
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 12, pg. 43
1/1/2007
Choosing the Safest Psoriasis Treatment for Women of Childbearing Potential
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 11, pg. 50-51
1/1/2007
Effective Strategies To Treat Intertriginous Psoriasis
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 10, pg. 54-58
1/1/2007
Responding to the Potential Effects of Obesity on Psoriasis
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 9, pg. 46-47
1/1/2007
Building Long-Term Relationships as a Patient Caregiver
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 8, pg. 53-54
1/1/2007
Get Familiar with the Biologics Safety Dance
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 7, pg. 17-18
1/1/2007
Guidelines for Use of PUVA and Tips for Success
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 6, pg. 56-57
1/1/2007
Psoriasis Research You and Your Patients Can Take to the Bank
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 5, pg. 56-58
1/1/2007
Exploring Off-Label Use of Biologics for Dermatologic Indications
Jerry Bagel, M.D., Practical Dermatology, Vol.4, No.5, pg.56-58
1/1/2007
Evaluating the Risks and Benefits of Soriatane
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 2, pg. 82-84
1/1/2007
New Perspectives on Methotrexate and Liver Biopsies
Jerry Bagel, M.D., Practical Dermatology, Vol. 4, No. 1, pg. 74-75
1/1/2007
How and When to Use Cyclosporine in Psoriasis Care
Jerry Bagel, M.D., Practical Dermatology, Vol..3, No. 12. pg. 58-61
1/1/2006
In the Pipeline: Promising Early Data for a New Biologic.
Jerry Bagel, M.D., Practical Dermatology, 3:11 pg. 25-26
1/1/2006
Approaches to Difficult-to-Treat Psoriasis in Specialized Areas.
Jerry Bagel, M.D., Practical Dermatology, 3:10 pg 48-50
1/1/2006
Unlock the Benefits of Phototherapy for Psoriasis
Jerry Bagel, M.D., Practical Dermatology, pg. 41
1/1/2006
A Guide to Introducing Biologic Therapies for Psoriasis into Clinical Practice
Jerry Bagel, M.D., et al, Precept Medical Communications
1/1/2002
Join now to see all

Press Mentions

Dermavant Presents New Patient Satisfaction Data from PSOARING 3 Long Term Extension Trial of Tapinarof in Adults with Plaque Psoriasis at the 2022 Winter Clinical Dermatology ConferenceJanuary 15th, 2022
Dr. Jennifer Soung Named New Psoriasis EditorAugust 16th, 2019
Biologics May Reduce Plaque Buildup in Psoriasis Patients’ ArteriesFebruary 5th, 2019
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow

Hospital Affiliations

Penn Medicine Princeton Medical CenterPlainsboro, New Jersey